ESC 365 - Navigating challenges: comorbidities impact patient risk and treatment efficacy

Open Access

Navigating challenges: comorbidities impact patient risk and treatment efficacy

Session: Cholesterol lowering in high cardiovascular risk patients with comorbidities: closing gaps and future opportunities

Topic: Lipid-Lowering Agents

Speaker: Doctor L. Perez De Isla (Madrid, ES)

Sponsored by Daiichi Sankyo

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Leopoldo Perez De Isla

San Carlos Clinical University Hospital, Madrid (Spain)

8 presentations

0 follower

4 more presentations in this session

Welcome and introduction

Speaker: Professor D. Connolly (Birmingham, GB)

Unmet needs: real-world evidence reveals treatment gaps in patients with diabetes and obesity

Speaker: Professor K. Parhofer (Munich, DE)

Closing the gap: advancing lipid management in high-risk patients with comorbidities

Speaker: Professor K. Ray (London, GB)

Panel discussion and Q&A

Speaker: Professor D. Connolly (Birmingham, GB) Professor K. Parhofer (Munich, DE) Professor K. Ray (London, GB) Doctor L. Perez De Isla (Madrid, ES)

Access the full session

Cholesterol lowering in high cardiovascular risk patients with comorbidities: closing gaps and future opportunities

Speakers: Doctor L. Perez De Isla, Professor D. Connolly, Professor K. Parhofer, Professor K. Ray, Professor D. Connolly...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources